Lupin gets tentative USFDA nod for Sitagliptin, Metformin Hydrochloride Tablets to treat type 2 diabetes Ruchika Sharma29 Nov 2024 3:32 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
Merck set to remove cancer-causing chemical from top diabetes drugs Ruchika Sharma18 Jan 2023 1:15 PM ISTNew Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...
Merck VS Mylan Pharma: US Court of Appeals for the Federal Circuit rules in favor of Merck in Sitagliptin Dihydrogen Phosphate patent lawsuit Ruchika Sharma2 Oct 2022 5:00 PM ISTThe ruling from the U.S. Court of Appeals provides JANUVIA, JANUMET and JANUMET XR patent protection through May 2027, which includes six (6) months...
USFDA says possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet Roshni Dhar13 Aug 2022 5:39 PM ISTThe U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and Janumet, were...
Health Bulletin 12/August/2022 Roshni Dhar12 Aug 2022 5:33 PM ISTHere are the Top Health stories for the day:Omicron is not mild for the frail, 32 deaths in Delhi in 10 daysThere have been 32 deaths in the past 10...
Possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet: USFDA Ruchika Sharma10 Aug 2022 5:08 PM ISTNew Delhi: The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and...
Aurobindo Pharma in legal battle with Merck over blockbuster diabetes drug Janumet Farhat Nasim26 Aug 2020 11:30 AM ISTHyderabad: In a major setback to Aurobindo Pharma, Merck Sharp & Dohme Corp, a subsidiary of Merck & Co has filed a petition in a US court...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 10:45 AM ISTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
